Biosimilar giant Celltrion to transform into drug developer

South Korean biosimilar giant Celltrion Group aims to transform into a drug developer by generating 40% of sales from new medicines by 2030 as it is...

S.Korea's Biorchestra signs tech transfer deal for drug delivery system

Biorchestra Co., a South Korean company specializing in RNA-based therapeutics, announced on Tuesday that it has entered into a joint research and o...

Korea's CJ Bioscience buys drug candidates from 4D pharma of the UK

South Korea’s pharmaceutical and healthcare company CJ Bioscience Inc. has acquired drug candidates from the UK's 4D pharma plc. to improve co...

Kwangdong introduces new drug candidate for pediatric myopia

South Korean pharmaceutical company Kwangdong Pharmaceutical announced on Monday that it has signed a contract with Hong Kong-based Zhaoke Ophthalmo...

JW Pharma receives 1st overseas patent for its hair loss treatment

JW Pharmaceutical, a drug company based in South Korea, has received its first patent for a hair loss treatment that is currently in development. Th...

S.Korea's ST Pharm supplies $49 mn worth of APIs to European drug firm

ST Pharm Co., a South Korean pharmaceutical firm, announced on Thursday that it had entered into an agreement to supply oligonucleotides to an undis...

Lunit's Insight DBT gets certification from EU for medical device

South Korean medical AI company Lunit said on Monday that its 3D breast tomosynthesis artificial intelligence (AI) image analysis solution, "Lunit I...

Prestige Bio's pancreatic cancer treatment gets US FDA fast-track designation

Prestige Biopharma, a biopharmaceutical company in South Korea, announced on Thursday that their pancreatic cancer antibody drug, PBP1510 (Ulenistam...

Noroo Paint, GS E&C jointly develop anti-carbonation paint for concrete

Noroo Paint, in collaboration with GS Engineering & Construction Co., announced on Tuesday the development of "Qfit Protect," a high-performance...

Samsung Bioepis launches ARMD biosimilar drug in Germany, Canada

Samsung Bioepis Co., a South Korean biosimilar firm, announced on Sunday that it has recently launched a new biosimilar drug called SB11 for the tre...

SKC earns ISO 37001 certification for anti-corruption management

SKC, the chemical materials unit of South Korea's second-largest conglomerate, announced on Thursday that it has received the ISO 37001 certificatio...

GC Biopharma introduces candidates for treating blood coagulation disease

South Korea's GC Biopharma Corp. announced on Tuesday that it had entered into an agreement to transfer assets with Catalyst Biosciences, a US-based...

Celltrion teams up with bio venture to develop new anti-cancer drug

South Korea's biopharmaceutical company Celltrion Inc. will develop an anti-cancer drug that combines oncolytic virus technology with biosimilars un...

Boryung signs deal with Stendhal to launch hypertension drug in Mexico

Boryung, a South Korean pharmaceutical company, said on Monday it had signed a deal with Stendhal SA de CV, a Mexican medical specialty company, to ...

SillaJen starts US trial of anti-cancer drug from Basilea

SillaJen Inc. said on Monday it has enrolled the first patient in a US phase 1 trial of an anti-cancer drug BAL0891 licensed from Swiss drugmaker Ba...

Korea's Daewoong to export diabetes drug Envlo to Brazil, Mexico

South Korea’s Daewoong Pharmaceutical Co. said on Feb. 24 it is set to embark on global sales of Envlo, a new drug for diabetes, by exportin...

Korea United Pharm signs contract to supply medicines to Saudi Arabia

Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...

SK Biopharm holds sales meeting for marketing Cenobamate in US

On Wednesday, SK Biopharmaceuticals Co. announced that its US subsidiary, SK Life Sciences Inc., held a "National Sales Meeting" in San Diego. The p...

Vaxcell-Bio, Cellid sign MOU to build cancer immunotherapy platform

Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...

HK inno.N's GERD drug K-CAB gets approval in Mexico

South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...

LG Chem builds S.Korea's first plant for clinical trials

LG Chem Ltd. has built South Korea’s first pharmaceutical plant dedicated to clinical trials, which the company expects to speed up its medici...

GC Biopharma, Sanofi to jointly market Plavix

GC Biopharma Co. (formerly Green Cross Corp.) said on Monday it has entered into a joint sales partnership with Sanofi-Aventis Korea, the South Kore...

Daewoong Pharma wins permission from Singapore for Nabota

South Korea's drug development company Daewoong Pharmaceutical said on Thursday that it received on Jan. 20 product approval for its botulinum toxin...

LIG Nex1 to work with Romanian state-run defense supplier

South Korea's defense contractor LIG Nex1 Co. will join hands with ROMARM, a Romanian state-run defense company, to develop anti-aircraft missiles a...

S.Korea's Lunit supplies breast cancer imaging solution to UAE

South Korean medical AI company Lunit has supplied its breast cancer imaging analysis solution — Agfa HealthCare Enterprise Imaging — to...

Hanmi Pharmaceutical reports record-high revenue in 2022

South Korea's Hanmi Pharmaceutical Co. last year saw record-high performance thanks to its self-developed drugs, surpassing its previous best year o...

S.Korea's InnoGene sets its public offering price at 3,000 won

InnoGene, which is seeking to be listed on the Kosdaq market at the end of this month, said on Wednesday that it has confirmed its offering price at...

S.Korea's Boryung receives EU GMP certification

South Korean pharmaceutical company Boryung announced that its production facility for anti-cancer injections in Yesan, South Chungcheong Province, ...

Chong Kun Dang, Synaffix ink deal to introduce ADC technology

Chong Kun Dang Pharmaceutical Corp. said on Monday that it has signed a contract with Dutch biotechnology firm Synaffix B.V for the use of antibody-...

Daewoong receives approval for its GERD drug Fexuclue in Ecuador

Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...